1. Home
  2. OPBK vs ENLV Comparison

OPBK vs ENLV Comparison

Compare OPBK & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OPBK

OP Bancorp

HOLD

Current Price

$14.25

Market Cap

185.7M

Sector

Finance

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.80

Market Cap

258.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPBK
ENLV
Founded
2005
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.7M
258.7M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
OPBK
ENLV
Price
$14.25
$0.80
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$16.50
$20.00
AVG Volume (30 Days)
35.5K
756.6K
Earning Date
04-23-2026
05-29-2026
Dividend Yield
3.37%
N/A
EPS Growth
23.74
N/A
EPS
1.72
N/A
Revenue
$3,204,000.00
N/A
Revenue This Year
$16.07
N/A
Revenue Next Year
$11.60
N/A
P/E Ratio
$8.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.03
$0.66
52 Week High
$15.27
$2.10

Technical Indicators

Market Signals
Indicator
OPBK
ENLV
Relative Strength Index (RSI) 66.37 37.33
Support Level $13.81 $0.81
Resistance Level $14.71 $1.19
Average True Range (ATR) 0.30 0.11
MACD 0.13 -0.01
Stochastic Oscillator 88.24 13.06

Price Performance

Historical Comparison
OPBK
ENLV

About OPBK OP Bancorp

OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: